Conditioning regimens for HSCT for patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukaemia

被引：0
|
作者：
Zhang, Xi [1 ,2 ]
机构：
[1] Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China
[2] Jinfeng Lab, Chongqing, Peoples R China
来源：
LANCET HAEMATOLOGY | 2023年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e159 / e160
页数：2
相关论文
共 50 条
  • [21] Sequential allogeneic stem cell transplantation in high risk acute myeloid leukaemia and myelodysplastic syndrome
    Zavrelova, A.
    Radocha, J.
    Lanska, M.
    Zak, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S526 - S526
  • [22] A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study
    Buckley, Sarah A.
    Percival, Mary-Elizabeth
    Othus, Megan
    Halpern, Anna B.
    Huebner, Emily M.
    Becker, Pamela S.
    Shaw, Carole
    Shadman, Mazyar
    Walter, Roland B.
    Estey, Elihu H.
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1023 - 1029
  • [23] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2157 - 2164
  • [24] Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
    Jain, Akriti G.
    Ball, Somedeb
    Aguirre, Luis
    Al Ali, Najla
    Kaldas, David
    Tinsley-Vance, Sara
    Kuykendall, Andrew
    Chan, Onyee
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami
    HAEMATOLOGICA, 2024, 109 (07) : 2157 - 2164
  • [25] A Comparison of Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Treated on Versus Off Study
    Buckley, Sarah A.
    Percival, Mary-Elizabeth M.
    Othus, Megan
    Halpern, Anna B.
    Huebner, Emily M.
    Shaw, Carole
    Hendrie, Paul C.
    Shadman, Mazyar
    Becker, Pamela S.
    Walter, Roland B.
    Estey, Elihu H.
    BLOOD, 2016, 128 (22)
  • [26] A Comparison of Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Treated On versus Off Study
    Percival, Mary-Elizabeth
    Buckley, Sarah
    Othus, Megan
    Halpern, Anna
    Huebner, Emily
    Becker, Pamela
    Shaw, Carole
    Shadman, Mazyar
    Walter, Roland
    Estey, Elihu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S281 - S281
  • [27] SINGLE CENTRE SURVIVAL OUTCOMES IN THE TREATMENT OF INTERMEDIATE AND HIGH-RISK MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKAEMIA WITH 5-AZACITIDINE
    Stringer, R.
    Rider, D. T.
    Newman, D. J.
    Grace, D. R.
    HAEMATOLOGICA, 2015, 100 : 725 - 726
  • [28] Maintenance therapy with decitabine after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Pusic, I.
    Choi, J.
    Bernabe, N.
    Abboud, C.
    Westervelt, P.
    Vij, R.
    Cashen, A.
    Uy, G.
    Stockerl-Goldstein, K.
    Holt, M.
    DiPersio, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S340 - S341
  • [29] CPX-351: an attractive option for the treatment of older patients with high-risk or secondary acute myeloid leukaemia
    Thomas, Xavier
    Plesa, Adriana
    LANCET HAEMATOLOGY, 2021, 8 (07): : E468 - +
  • [30] Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study
    Ravandi, Farhad
    Assi, Rita
    Daver, Naval
    Benton, Christopher B.
    Kadia, Tapan
    Thompson, Philip A.
    Borthakur, Gautam
    Alvarado, Yesid
    Jabbour, Elias J.
    Konopleva, Marina
    Takahashi, Koichi
    Kornblau, Steven
    DiNardo, Courtney D.
    Estrov, Zeev
    Flores, Wilmer
    Basu, Sreyashi
    Allison, James
    Sharma, Padmanee
    Pierce, Sherry
    Pike, Allison
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    LANCET HAEMATOLOGY, 2019, 6 (09): : E480 - E488
12345